CLNN
Price
$2.69
Change
-$0.36 (-11.80%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
26.24M
DARE
Price
$2.90
Change
-$0.04 (-1.37%)
Updated
Apr 4, 04:53 PM (EDT)
Capitalization
25.58M
Ad is loading...

CLNN vs DARE

Header iconCLNN vs DARE Comparison
Open Charts CLNN vs DAREBanner chart's image
Clene
Price$2.69
Change-$0.36 (-11.80%)
Volume$280
Capitalization26.24M
Dare Bioscience
Price$2.90
Change-$0.04 (-1.37%)
Volume$150
Capitalization25.58M
CLNN vs DARE Comparison Chart
Loading...
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLNN vs. DARE commentary
Apr 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLNN is a StrongBuy and DARE is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 06, 2025
Stock price -- (CLNN: $3.05 vs. DARE: $2.93)
Brand notoriety: CLNN and DARE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLNN: 81% vs. DARE: 44%
Market capitalization -- CLNN: $26.24M vs. DARE: $25.58M
CLNN [@Biotechnology] is valued at $26.24M. DARE’s [@Biotechnology] market capitalization is $25.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLNN’s FA Score shows that 0 FA rating(s) are green whileDARE’s FA Score has 0 green FA rating(s).

  • CLNN’s FA Score: 0 green, 5 red.
  • DARE’s FA Score: 0 green, 5 red.
According to our system of comparison, both CLNN and DARE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLNN’s TA Score shows that 4 TA indicator(s) are bullish while DARE’s TA Score has 4 bullish TA indicator(s).

  • CLNN’s TA Score: 4 bullish, 4 bearish.
  • DARE’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, DARE is a better buy in the short-term than CLNN.

Price Growth

CLNN (@Biotechnology) experienced а -4.09% price change this week, while DARE (@Biotechnology) price change was +1.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.75%. For the same industry, the average monthly price growth was -16.58%, and the average quarterly price growth was -18.37%.

Reported Earning Dates

CLNN is expected to report earnings on Aug 12, 2024.

DARE is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (-10.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLNN($26.2M) and DARE($25.6M) have the same market capitalization . DARE YTD gains are higher at: -6.090 vs. CLNN (-42.561). DARE has higher annual earnings (EBITDA): -23.19M vs. CLNN (-29.61M). CLNN has more cash in the bank: 14.6M vs. DARE (11.2M). DARE has less debt than CLNN: DARE (1.4M) vs CLNN (22.9M). DARE has higher revenues than CLNN: DARE (1.88M) vs CLNN (421K).
CLNNDARECLNN / DARE
Capitalization26.2M25.6M102%
EBITDA-29.61M-23.19M128%
Gain YTD-42.561-6.090699%
P/E RatioN/A0.10-
Revenue421K1.88M22%
Total Cash14.6M11.2M130%
Total Debt22.9M1.4M1,631%
FUNDAMENTALS RATINGS
CLNN vs DARE: Fundamental Ratings
CLNN
DARE
OUTLOOK RATING
1..100
5275
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9479
P/E GROWTH RATING
1..100
9675
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DARE's Valuation (69) in the Biotechnology industry is in the same range as CLNN (83) in the null industry. This means that DARE’s stock grew similarly to CLNN’s over the last 12 months.

DARE's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CLNN (100) in the null industry. This means that DARE’s stock grew similarly to CLNN’s over the last 12 months.

DARE's SMR Rating (100) in the Biotechnology industry is in the same range as CLNN (100) in the null industry. This means that DARE’s stock grew similarly to CLNN’s over the last 12 months.

DARE's Price Growth Rating (79) in the Biotechnology industry is in the same range as CLNN (94) in the null industry. This means that DARE’s stock grew similarly to CLNN’s over the last 12 months.

DARE's P/E Growth Rating (75) in the Biotechnology industry is in the same range as CLNN (96) in the null industry. This means that DARE’s stock grew similarly to CLNN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLNNDARE
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
69%
Bullish Trend 5 days ago
80%
Momentum
ODDS (%)
Bearish Trend 5 days ago
75%
Bearish Trend 5 days ago
87%
MACD
ODDS (%)
Bearish Trend 5 days ago
81%
Bullish Trend 5 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
85%
Bullish Trend 5 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
80%
Advances
ODDS (%)
Bullish Trend 20 days ago
80%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 17 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
89%
Bullish Trend 5 days ago
79%
Aroon
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
79%
View a ticker or compare two or three
Ad is loading...
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X83102.830000617.109400
+0.75%
Bitcoin cryptocurrency
SPY536.70-27.82
-4.93%
SPDR® S&P 500® ETF Trust
TSLA267.28-15.48
-5.47%
Tesla
GME21.10-1.59
-7.01%
GameStop Corp
AAPL203.19-20.70
-9.25%
Apple

CLNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLNN has been closely correlated with RIGL. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLNN jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLNN
1D Price
Change %
CLNN100%
+1.67%
RIGL - CLNN
92%
Closely correlated
-3.05%
DARE - CLNN
88%
Closely correlated
+0.69%
HOOK - CLNN
86%
Closely correlated
-7.22%
PHIO - CLNN
83%
Closely correlated
-3.31%
IMRN - CLNN
80%
Closely correlated
+2.86%
More

DARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, DARE has been closely correlated with RIGL. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if DARE jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DARE
1D Price
Change %
DARE100%
+0.69%
RIGL - DARE
88%
Closely correlated
-3.05%
CLNN - DARE
88%
Closely correlated
+1.67%
HOOK - DARE
87%
Closely correlated
-7.22%
PHIO - DARE
81%
Closely correlated
-3.31%
AZTR - DARE
78%
Closely correlated
-1.48%
More